Asahi Intecc Co., Ltd. (TYO:7747)
2,366.50
-35.00 (-1.46%)
Oct 1, 2025, 3:30 PM JST
Asahi Intecc Revenue
In the fiscal year ending June 30, 2025, Asahi Intecc had annual revenue of 120.03B JPY with 11.60% growth. Asahi Intecc had revenue of 28.21B in the quarter ending June 30, 2025, with 5.21% growth.
Revenue
120.03B
Revenue Growth
+11.60%
P/S Ratio
5.35
Revenue / Employee
12.81M
Employees
9,371
Market Cap
641.83B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Jun 30, 2025 | 120.03B | 12.48B | 11.60% |
Jun 30, 2024 | 107.55B | 17.45B | 19.36% |
Jun 30, 2023 | 90.10B | 12.35B | 15.89% |
Jun 30, 2022 | 77.75B | 16.24B | 26.41% |
Jun 30, 2021 | 61.51B | 4.96B | 8.77% |
Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Chugai Pharmaceutical | 1,196.21B |
HOYA Corporation | 876.09B |
Takeda Pharmaceutical Company | 4,480.25B |
Daiichi Sankyo Company | 1,924.68B |
Otsuka Holdings | 2,401.70B |
Terumo | 1,037.94B |
Astellas Pharma | 1,944.99B |
Shionogi & | 440.50B |